Red Blood Cell Alloimmunizations in Thalassaemia Patients With Regular Transfusion in China: a Systematic Review and Meta-Analysis.

[1]  J. Chiaroni,et al.  An overview of red blood cell and platelet alloimmunisation in transfusion. , 2022, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[2]  E. Khodadi,et al.  Red Blood Cell Alloimmunization Rates and Related Factors of Patients with Thalassemia in Shiraz, Iran. , 2021, Laboratory medicine.

[3]  Junqi Wu,et al.  [Detection of Irregular Antibodies after Blood Transfusion for Children with Thalassemia in Hainan]. , 2021, Zhongguo shi yan xue ye xue za zhi.

[4]  H. Majidiani,et al.  Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran , 2020, BioImpacts : BI.

[5]  A. A. Salama,et al.  A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients , 2020, Scientific Reports.

[6]  A. Dorgalaleh,et al.  Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr. , 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[7]  L. Estcourt,et al.  The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England , 2020, Transfusion medicine.

[8]  V. Yahalom,et al.  Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel , 2020, Annals of Hematology.

[9]  S. Hindawi,et al.  The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center , 2020, Transfusion.

[10]  C. Westhoff,et al.  How do I incorporate red cell genotyping to improve chronic transfusion therapy? , 2019, Transfusion.

[11]  M. Benajiba,et al.  Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors. , 2019, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[12]  C. Puapairoj,et al.  The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐matched red blood cells for thalassemia transfusions: a 10‐year experience at a tertiary care hospital , 2018, Transfusion.

[13]  E. Vichinsky,et al.  Transfusion practices and complications in thalassemia , 2018, Transfusion.

[14]  Jenna Khan,et al.  Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors , 2018, Transfusion Medicine and Hemotherapy.

[15]  R. Strauss,et al.  Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods , 2018, Transfusion.

[16]  S. Kulkarni,et al.  Molecular genotyping of clinically important blood group antigens in patients with thalassaemia , 2018, The Indian journal of medical research.

[17]  D. Weatherall,et al.  Thalassaemia , 2018, The Lancet.

[18]  K. Davari,et al.  Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients , 2016, Asian journal of transfusion science.

[19]  G. Burazeri,et al.  Frequency and specificity of red cell antibodies in thalassemia patients in Albania , 2015, International journal of laboratory hematology.

[20]  M. Borhany,et al.  Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan , 2015, Transfusion medicine.

[21]  O. Tangvarasittichai,et al.  Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients , 2015, Indian Journal of Clinical Biochemistry.

[22]  L. Pierelli,et al.  Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing , 2014, Vox sanguinis.

[23]  K. Hue‐Roye,et al.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. , 2014, Blood cells, molecules & diseases.

[24]  R. Jain,et al.  Detection and Identification of Red Cell Alloantibodies in Multiply Transfused Thalassemia Major Patients: A Prospective Study , 2014, Indian Journal of Hematology and Blood Transfusion.

[25]  M. Large,et al.  Meta-analysis A systematic review and meta-regression analysis of aggression during the First Episode of Psychosis , 2013 .

[26]  Jang-Jih Lu,et al.  Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. , 2013, Blood transfusion = Trasfusione del sangue.

[27]  C. Lee,et al.  Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review , 2012, Transfusion.

[28]  G. Stamatoyannopoulos,et al.  Thalassaemia , 2012, The Lancet.

[29]  Ou Xiao-bing.  Study on screening and identification of serum irregular antibodies in children withβ Thalassema major , 2012 .

[30]  E. Neufeld,et al.  Red cell alloimmunization in a diverse population of transfused patients with thalassaemia , 2011, British journal of haematology.

[31]  M. Coory,et al.  Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2010, International journal of epidemiology.

[32]  S. Shepperd,et al.  The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. , 2009, AIDS Reviews.

[33]  D. Liang,et al.  Alloimmunization among patients with transfusion‐dependent thalassemia in Taiwan , 2006, Transfusion medicine.

[34]  S. Al-Shemmari,et al.  RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients , 2003, Transfusion.

[35]  Y. Lau,et al.  Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. , 2001, Blood.

[36]  E. Vichinsky,et al.  Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. , 2000, Blood.